Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

431696

registered interest
date	23/11/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prescription Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what research his Department has conducted on the disincentives to prescribing off-patent repurposed drugs.
tabling member constituency	Glasgow North West
tabling member printed	Carol Monaghan
uin	17150
answer	answer is ministerial correction date of answer 01/12/2015 answer text <p>The Department has conducted no such research. Current arrangements already allow off-patent drugs to be prescribed for new purposes where this is the most appropriate clinical treatment course for a patient. Prescribing decisions are a matter for the clinical judgement of the prescriber concerned.</p><br /> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 01/12/2015 16:49:32 answering member 4020 label Biography information for George Freeman
tabling member	4443 label Biography information for Carol Monaghan

431700

registered interest
date	23/11/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Off-patent Drugs Bill
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the contribution of 6 November 2015 by the Minister for Community and Social Care, Official Report, column 1307, what the evidential basis is for his statement that the provisions of the Off-patent Drugs Bill would be potentially harmful.
tabling member constituency	Glasgow North West
tabling member printed	Carol Monaghan
uin	17208
answer	answer is ministerial correction date of answer 01/12/2015 answer text <p>The current legal framework allows a clinician to prescribe drugs outside their licensed indication where that will best meet the clinical needs of their patient. This clinical freedom is crucial in delivering appropriate healthcare to groups of patients for whom medicines have not historically been licensed, e.g. children. It is also helpful in enabling prescribers to quickly pick up and apply new evidence that will help patients with particular clinical needs. The Off-Patent Drugs Bill would introduce a legal duty to apply for a licence for off-patent drugs where evidence of effectiveness for a new indication becomes available. This will create an expectation that only licensed uses of drugs are acceptable and therefore that off-label use is not appropriate. This would cause unnecessary delays in patients getting the medicines they need by slowing the rapid uptake of new evidence in clinical practice. This is why we believe the proposed legislation could potentially be harmful.</p><br /> <br /> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 01/12/2015 16:45:34 answering member 4020 label Biography information for George Freeman
tabling member	4443 label Biography information for Carol Monaghan